PRA Health Sciences inc (NASDAQ:PRAH) currently has a “Hold” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.
PRA Health Sciences inc (NASDAQ:PRAH) lost -0.08 Percent and closed its previous trading session at $101.14. The stock traded with the average Volume of 875.47 Million at the end of last session.
PRA Health Sciences inc (NASDAQ:PRAH) has the Market Capitalization of 6.46 Billion. The Stock has its 52-week High of $108.02 and 52-Week Low of $ 73.23 and it touched its 52-week high on 07/26/18 and 52-Week Low on 09/15/17
The company reported its last earnings Actual EPS of $1/share. While, the analyst predicted that the company could provide an EPS of $0.96/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.04/share which shows an Earnings Surprise of 4.2 Percent.
Sell side analysts plays vital role in buying and selling a stock where 1 analysts rated PRA Health Sciences inc (NASDAQ:PRAH) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 1 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.92% where SMA50 and SMA200 are 4.7% and 14.34% respectively.
The company shows its Return on Assets (ROA) value of 3.4%. The Return on Equity (ROE) value stands at 12.1%. While it’s Return on Investment (ROI) value is 8.2%.
PRA Health Sciences inc (NASDAQ:PRAH) currently has a Weekly Volatility of 2.49% percent while its Monthly Volatility is at 2.59% percent. While talking about Performance of the Stock, PRA Health Sciences inc currently has a Weekly performance of -3.72%, monthly performance percentage is 3.33 percent, Quarterly performance is 24.8 percent, 6 months performance shows a percent value of 20.48% and Yearly Performance is 36.44 percent.
PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina.